Combining objective and subjective outcomes in cancer-related fatigue: Illustrations from a single case report

Journal of Palliative Medicine

Volumn 11, Issue 6, 2008, Pages 829-833

  Khoshknabi, Dilara Seyidova ^a   Davis, Mellar P ^a   Ranganathan, Vinoth K ^a   Siemionow, Vlodek ^a   Walsh, Declan ^a   Kirkova, Jordanka ^a   Yue, Guang H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; CANCER FATIGUE; CANCER STAGING; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE TITRATION; FEMALE; HUMAN; LUNG CANCER; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; SCORING SYSTEM; SMOKING; TREATMENT RESPONSE;

CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE; FEMALE; HUMANS; LUNG NEOPLASMS; METHYLPHENIDATE; MIDDLE AGED; NEUROLOGIC EXAMINATION;

EID: 50049125937     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2007.0295     Document Type: Article

References (29)

1. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA cooperative group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 1999;56:1073-1086.
2. Abikoff H, Hechtman L, Klein RG, Weiss G, Fleiss K, Etcovitch J, Cousins L, Greenfield B, Martin D, Pollack S: Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 2004;43:802-811.
3. Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-2078.
4. Hallett M: Movement-related cortical potentials. Electromyogr Clin Neurophysiol 1994;34:5-13.
5. Rappley MD: Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med 2005;352:165-173.
6. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34:4-12.
7. Meyers CA, Weitzner MA, Valentine AD, Levin VA: Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16:2522-2527.
8. Homsi J, Nelson KA, Sarhill N, Levin VA: A phase II study of methylphenidate for depression in advanced cancer. Am J Hosp Palliat Care 2001;18:403-407.
9. Fernandez F, Adams F: Methylphenidate treatment of patients with head and neck cancer. Head Neck Surg 1986;8:296-300.
10. DeLong R, Friedman H, Friedman N, Zajicek G, Treves AJ, Laufer N: Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol 1992;7:462-463.
11. Weitzner MA, Meyers CA, Valentine AD: Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci 1995;7:347-350.
12. Walsh D, Doona M, Molnar M, Lipnickey V: Symptom control in advanced cancer: Important drugs and routes of administration. Semin Oncol 2000;27:69-83.
13. Homsi J, Walsh D, Nelson KA, LeGrand S, Davis M: Methylphenidate for depression in hospice practice: A case series. Am J Hosp Palliat Care 2000;17:393-398.
14. Sarhill N, Walsh D, Nelson KA, Homsi J, LeGrand S, Davis MP: Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study. Am J Hosp Palliat Care 2001;18:187-192.
15. Sood A, Barton DL, Loprinzi CL: Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care 2006;23:35-40.
16. Hanna A, Sledge G, Mayer ML, Hanna N, Einhorn L, Monahan P, Daggy J, Bhatia S: A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 2006;14:210-215.
17. Davey NJ, Puri BK, Nowicky AV, Main J, Zaman R: Voluntary motor function in patients with chronic fatigue syndrome. J Psychosom Res 2001;50:17-20.
18. Siemionow V, Fang Y, Nair P, Sahgal V, Calabrese L, Yue GH: Brain activity during voluntary motor activities in chronic fatigue syndrome [abstract]. Soc Neurosci Abstr 2001;27:12.
19. Starr A, Scalise A, Gordon R, Michalewski HJ, Caramia MD: Motor cortex excitability in chronic fatigue syndrome. Clin Neurophysiol 2000;111:2025-2031.
20. Siemionow V, Yue GH, Ranganathan VK, Liu JZ, Sahgal V: Relationship between motor activity-related cortical potential and voluntary muscle activation. Exp Brain Res 2000;133:303-311.
21. Yao B, Yue GH, Liu JZ: Time-frequency analysis of EEG data during muscle fatigue [abstract]. Soc Neurosci Abstr 2002;28:459.
22. Yue GH, Liu JZ, Siemionow V, Ranganathan VK, Ng TC, Sahgal V: Brain activation during human finger extension and flexion movements. Brain Res 2000;856:291-300.
23. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL: The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory. Cancer 1999;85:1186-1196.
24. Mota DD, Pimenta CA: Self-report instruments for fatigue assessment: A systematic review. Res Theory Nurs Pract 2006;20:49-78.
25. Yavuzsen T, Davis MP, Kirkova J, Ranganathan VK, Walsh D: Cancer related fatigue: Central or peripheral [abstract]. EAPC Abstract Book 2006:154.
26. Schneider T, Neumaier A: Algorithm 808: ARfit - A Matlab Package for the Estimation of Parameters and Eigenmodes of Multivariate Autoregressive Models, ACM Trans Math Softw 2001;27:58-65.
27. Sacco P, Hope PA, Thickbroom GW, Byrnes ML, Mastaglia FL: Corticomotor excitability and perception of effort during sustained exercise in the chronic fatigue syndrome. Clin Neurophysiol 1999;110:1883-1891.
28. Samii A, Wassermann EM, Ikoma K, Mercuri B, George MS, O'Fallon A, Dale JK, Straus SE, Hallett M: Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression. Neurology 1996;47:1410-1414.
29. Taylor JL, Gandevia SC: Transcranial magnetic stimulation and human muscle fatigue. Muscle Nerve 2001;24:18-29.